OncoRes Medical receives $12.5M in latest funding to pursue clinical trials
- May 24, 2022
- 1 min read
Updated: Feb 16
24 May 2022 / Adam Ang / MobiHealth News
The company develops a breakthrough device for detecting residual cancer tissues.
OncoRes medical device. (Supplied)
Excerpt from article:
Perth-based medical device firm OncoRes Medical has bagged $12.5 million in funding to support its upcoming clinical trials.
It recently scored $9.5 million in a Series A2 funding co-led by VC Brandon Capital and Future of Healthcare Fund by Australian Unity. A separate $3 million funding was secured from the Round 12 grant of the Cooperative Research Centres Projects of AusIndustry, the business programme arm of Australia's Department of Industry, Science, Energy and Resources.
This article was first published by MobiHealth News. Click here for full article.
Comments